ABA. Paige Brock

A. Paige Brock

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. Paige Brock has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • April L. Childress

    Department of Small Animal Clinical Sciences (Brock, Cortés-Hinojosa, Plummer, Childress, Wellehan), College of Veterinary Medicine, University of Florida, Gainesville, FL

    2 shared publications
  • Robert Paul Hunter

    One Medicine Consulting Olathe Kansas USA

    2 shared publications
  • Alexander E. Gallagher

    Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32608

    1 shared publication
  • Amber B. Schoeller

    Department of Small Animal Clinical Sciences , College of Veterinary Medicine, University of Florida , Gainesville , FL , USA

    1 shared publication
  • Caryn E. Plummer

    Department of Small Animal Clinical Sciences (Brock, Cortés-Hinojosa, Plummer, Childress, Wellehan), College of Veterinary Medicine, University of Florida, Gainesville, FL

    1 shared publication
  • Charles Arthur Peloquin

    College of Pharmacy and Emerging Pathogens Institute, University of Florida , Gainesville, Florida

    1 shared publication

Latest Publications

  • The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus)

    by A. P. Brock, R. Isaza, E. F. Egelund, R. P. Hunter, C. A. Peloquin

    Tuberculosis, caused by Mycobacterium tuberculosis, is a disease of concern in captive Asian elephants (Elephas maximus). Treatment for tuberculosis in elephants utilizes multidrug protocols combining isoniazid, rifampin, pyrazinamide, and/or ethambutol. In this study, a single, coformulated dose of isoniazid 5 mg/kg, rifampin 10 mg/kg, pyrazinamide 30 mg/kg, and ethambutol 30 mg/kg was administered orally to six Asian elephants, and rectally to five elephants using a cross‐over design. Blood samples were collected serially over 24 h. Pyrazinamide and ethambutol concentrations were determined using validated gas chromatography assays. Isoniazid and rifampin concentrations were determined using validated high‐performance liquid chromatography assays. Rectal isoniazid produced an earlier Tmax compared with oral administration. Oral isoniazid resulted in a comparatively lower Cmax, but higher AUC values compared with rectal isoniazid. Oral rifampin and oral ethambutol were well absorbed while rectal rifampin was not. Oral pyrazinamide produced comparatively higher Cmax and AUC values compared with rectal pyrazinamide. Results of this study indicate that currently recommended therapeutic monitoring sample collection times for rectal isoniazid and oral rifampin do not provide an accurate assessment of exposure for these drugs. This study demonstrates notable individual variability, indicating that dosing of these medications requires individual monitoring and provides additional information to guide the clinician when treating elephants.


  • DIAGNOSIS AND MANAGEMENT OF ATYPICAL HYPOADRENOCORTICISM IN A VARIABLE FLYING FOX (PTEROPUS HYPOMELANUS)

    by A. Paige Brock, Natalie H. Hall, Kirsten L. Cooke, David J. Reese, Jessica A. Emerson, James F. X. Wellehan

    A 19-yr-old intact female variable flying fox (Pteropus hypomelanus) presented with lethargy, behavior changes, and substantial weight loss. Initial clinical pathology revealed hypoglycemia and reduced ionized serum calcium, and imaging, including computed tomography, did not lead to a diagnosis. An adrenocorticotropic hormone (ACTH) stimulation test revealed baseline and post-ACTH cortisol concentrations that were lower than reported normal baseline cortisol concentrations in this species. Treatment with prednisolone resolved the clinical signs and laboratory abnormalities. Repeated attempts to decrease the prednisolone dose caused recurrence of clinical signs and weight loss. Based on diagnostic test results and response to therapy, a diagnosis of atypical hypoadrenocorticism was made.


  • Open Access

    A novel gammaherpesvirus in a large flying fox (Pteropus vampyrus) with blepharitis

    by A. Paige Brock, Galaxia Cortés-Hinojosa, Caryn E. Plummer, Julia A. Conway, Shannon R. Roff, April L. Childress, Jr. James F. X. Wellehan

    A novel gammaherpesvirus was identified in a large flying fox (Pteropus vampyrus) with conjunctivitis, blepharitis, and meibomianitis by nested polymerase chain reaction and sequencing. Polymerase chain reaction amplification and sequencing of 472 base pairs of the DNA-dependent DNA polymerase gene were used to identify a novel herpesvirus. Bayesian and maximum likelihood phylogenetic analyses indicated that the virus is a member of the genus Percavirus in the subfamily Gammaherpesvirinae. Additional research is needed regarding the association of this virus with conjunctivitis and other ocular pathology. This virus may be useful as a biomarker of stress and may be a useful model of virus recrudescence in Pteropus spp.


  • Open Access

    Estimates of the pharmacokinetics of famciclovir and its active metabolite penciclovir in young Asian elephants (Elephas maximus)

    by A. Paige Brock, Ramiro Isaza, Robert P. Hunter, Laura K. Richman, Richard J. Montali, Dennis L. Schmitt, David E. Koch, William A. Lindsay

    Objective —To determine plasma pharmacokinetics of penciclovir following oral and rectal administration of famciclovir to young Asian elephants ( Elephas maximus ). Animals —6 healthy Asian elephants (5 females and 1 male), 4.5 to 9 years old and weighing 1,646 to 2,438 kg. Procedures —Famciclovir was administered orally or rectally in accordance with an incomplete crossover design. Three treatment groups, each comprising 4 elephants, received single doses of famciclovir (5 mg/kg, PO, or 5 or 15 mg/kg, rectally); there was a minimum 12-week washout period between subsequent famciclovir administrations. Serial blood samples were collected after each administration. Samples were analyzed for famciclovir and penciclovir with a validated liquid chromatography–mass spectroscopy assay. Results —Famciclovir was tolerated well for both routes of administration and underwent complete biotransformation to the active metabolite, penciclovir. Mean maximum plasma concentration of penciclovir was 1.3 μg/mL at 1.1 hours after oral administration of 5 mg/kg. Similar results were detected after rectal administration of 5 mg/kg. Mean maximum plasma concentration was 3.6 μg/mL at 0.66 hours after rectal administration of 15 mg/kg; this concentration was similar to results reported for humans receiving 7 mg/kg orally. Conclusions and Clinical Relevance —Juvenile Asian elephants are susceptible to elephant endotheliotropic herpesvirus. Although most infections are fatal, case reports indicate administration of famciclovir has been associated with survival of 3 elephants. In Asian elephants, a dose of 8 to 15 mg of famciclovir/kg given orally or rectally at least every 8 hours may result in penciclovir concentrations that are considered therapeutic in humans.


  • Open Access

    Kiricephalus coarctatusin an Eastern Indigo Snake (Drymarchon couperi); endoscopic removal, identification, and phylogeny.

    by A. Paige Brock, Alexander E. Gallagher, Heather D. Stockdale Walden, Jennifer L. Owen, Mark D. Dunbar, Heather L. Wamsley, Amber B. Schoeller, April L. Childress, James F.X. Wellehan